newsfilter
← Latest News
GlobeNewswire·

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

Bionomics has collaborated with MSD to identify novel α7 nAChR PAMs suitable for the treatment of cognitive disorders like Alzheimer's DiseaseBased on the learnings from Bionomics' candidate BNC375, additional candidates